EUMOVATE

This brand name is authorized in Hong Kong SAR China, Ireland, Malta, New Zealand, South Africa, Turkey, UK.

Active ingredients

The drug EUMOVATE contains one active pharmaceutical ingredient (API):

1	Clobetasone UNII 8U0H6XI6EO - CLOBETASONE BUTYRATE
	Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema.
	Read more about Clobetasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EUMOVATE Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AB01	Clobetasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II)
Discover more medicines within D07AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	175586, 19270, 19271, 19273, 19275, 19276
HK	Department of Health Drug Office	06945
IE	Health Products Regulatory Authority	23116, 23124
MT	Medicines Authority	MA192/03901
NZ	Medicines and Medical Devices Safety Authority	12457, 2394
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522350810, 8699522356522, 8699522380824, 8699522386581
ZA	Health Products Regulatory Authority	J/13.4.1/187, J/13.4.1/188